Rheumatoid Arthritis Basic Science Studies

You have full text access to this OnlineOpen article

Antibodies against citrullinated vimentin in rheumatoid arthritis: Higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides†

  1. Linda Mathsson1,
  2. Mohammed Mullazehi1,
  3. Marius C. Wick2,5,
  4. Olof Sjöberg1,
  5. Ronald van Vollenhoven3,
  6. Lars Klareskog3,‡,
  7. Johan Rönnelid4,6,*

Article first published online: 28 DEC 2007

DOI: 10.1002/art.23188

Issue

Arthritis & Rheumatism

Arthritis & Rheumatism

Volume 58, Issue 1, pages 36–45, January 2008

Additional Information

How to Cite

Mathsson, L., Mullazehi, M., Wick, M. C., Sjöberg, O., van Vollenhoven, R., Klareskog, L. and Rönnelid, J. (2008), Antibodies against citrullinated vimentin in rheumatoid arthritis: Higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides. Arthritis & Rheumatism, 58: 36–45. doi: 10.1002/art.23188

Author Information

  1. 1

    Uppsala University, Uppsala, Sweden

  2. 2

    Karolinska Institute, Stockholm, Sweden

  3. 3

    Karolinska Institute, Stockholm, Sweden

  4. 4

    Uppsala University, Uppsala, Sweden

  5. 5

    Innsbruck Medical University, Innsbruck, Austria

  6. 6

    Karolinska Institute, Stockholm, Sweden

  1. ‡

    Dr. Klareskog has received consulting fees, speaking fees, and/or honoraria (less than $10,000 each) from Wyeth, Schering-Plough, Bristol-Myers Squibb, Abbott, Roche, and Amgen. Dr. Rönnelid has received speaking fees (less than $10,000 each) from Schering-Plough, Wyeth, Pfizer, and Roche.

*Unit of Clinical Immunology, Rudbeck Laboratory C5, Uppsala University, SE-751 85 Uppsala, Sweden

  1. †

    Orgentec Inc. supplied anti-MCV kits for the study.

Publication History

  1. Issue published online: 28 DEC 2007
  2. Article first published online: 28 DEC 2007
  3. Manuscript Accepted: 7 SEP 2007
  4. Manuscript Received: 26 NOV 2006

Funded by

  • Swedish Fund for Research Without Animal Experiments
  • Agnes and Mac Rudberg Foundation
  • King Gustav V's 80-Year Fund
  • Signe and Reinhold Sund's Foundation for Rheumatological Research
  • Swedish Rheumatism Association

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (239K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Nóra Bodnár, Zoltán Szekanecz, Zoltán Prohászka, Ádám Kemény-Beke, Zsuzsanna Némethné-Gyurcsik, Katalin Gulyás, Gabriella Lakos, Sándor Sipka, Sándor Szántó, Anti-mutated citrullinated vimentin (anti-MCV) and anti-65kDa heat shock protein (anti-hsp65): New biomarkers in ankylosing spondylitis, Joint Bone Spine, 2012, 79, 1, 63

    CrossRef

  2. 2
    Nóra Bodnár, Zoltán Szekanecz, Zoltán Prohászka, Ádám Kemény-Beke, Zsuzsanna Némethné-Gyurcsik, Katalin Gulyás, Gabriella Lakos, Sándor Sipka, Sándor Szántó, Anticorps antivimentine citrullinée (anti-MCV) et antiprotéine du choc thermique de 65kDa (anti-hsp65) : nouveaux biomarqueurs dans la spondylarthrite ankylosante, Revue du Rhumatisme, 2012, 79, 1, 52

    CrossRef

  3. 3
    Elena Bartoloni, Alessia Alunno, Onelia Bistoni, Nicola Bizzaro, Paola Migliorini, Gabriella Morozzi, Andrea Doria, Alessandro Mathieu, Milvia Lotzniker, Flavio Allegri, Valeria Riccieri, Claudia Alpini, Armando Gabrielli, Marilina Tampoia, Roberto Gerli, Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: An Italian multicentric study and review of the literature, Autoimmunity Reviews, 2012,

    CrossRef

  4. 4
    Lyudmila Sizova, Diagnostic value of antibodies to modified citrullinated vimentin in early rheumatoid arthritis, Human Immunology, 2012, 73, 4, 389

    CrossRef

  5. 5
    Nishant Dwivedi, Jagriti Upadhyay, Indira Neeli, Salar Khan, Debendra Pattanaik, Linda Myers, Kyriakos A. Kirou, Bernhard Hellmich, Bryan Knuckley, Paul R. Thompson, Mary K. Crow, Ted R. Mikuls, Elena Csernok, Marko Radic, Felty's syndrome autoantibodies bind to deiminated histones and neutrophil extracellular chromatin traps, Arthritis & Rheumatism, 2012, 64, 4
    Direct Link:
  6. 6
    Ulrike Harre, Dan Georgess, Holger Bang, Aline Bozec, Roland Axmann, Elena Ossipova, Per-Johan Jakobsson, Wolfgang Baum, Falk Nimmerjahn, Eszter Szarka, Gabriella Sarmay, Grit Krumbholz, Elena Neumann, Rene Toes, Hans-Ulrich Scherer, Anca Irinel Catrina, Lars Klareskog, Pierre Jurdic, Georg Schett, Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin, Journal of Clinical Investigation, 2012,

    CrossRef

  7. 7
    Andrea Tesija Kuna, Mutated citrullinated vimentin antibodies in rheumatoid arthritis, Clinica Chimica Acta, 2012, 413, 1-2, 66

    CrossRef

  8. 8
    Somia H. Abd-Allah, Amal S. El-Shal, Sally M. Shalaby, Heba F. Pasha, Amany M. Abou El-Saoud, Amany R. El-Najjar, Eman E. El-Shahawy, PADI4 polymorphisms and related haplotype in rheumatoid arthritis patients, Joint Bone Spine, 2012, 79, 2, 124

    CrossRef

  9. 9
    Walther J. van Venrooij, Joyce J. B. C. van Beers, Ger J. M. Pruijn, Anti-CCP antibodies: the past, the present and the future, Nature Reviews Rheumatology, 2011, 7, 7, 391

    CrossRef

  10. 10
    Raimon Sanmartí, José A. Gómez-Puerta, Biomarcadores en la artritis reumatoide, Reumatología Clínica, 2011, 6, 25

    CrossRef

  11. 11
    Jian YIN, Ting LI, Jun BAO, Hu-ji XU, Detection of anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis: the clinical significance, Academic Journal of Second Military Medical University, 2011, 31, 9, 1023

    CrossRef

  12. 12
    Brooke E Gilliam, Melinda R Reed, Anil K Chauhan, Amanda B Dehlendorf, Terry L Moore, Evidence of fibrinogen as a target of citrullination in IgM rheumatoid factor-positive polyarticular juvenile idiopathic arthritis, Pediatric Rheumatology, 2011, 9, 1, 8

    CrossRef

  13. 13
    Marc K. Jenkins, Daniel Mueller, On the trail of arthritogenic T cells, Arthritis & Rheumatism, 2011, 63, 10
    Direct Link:
  14. 14
    Somia H. Abd-Allah, Amal S. El-Shal, Sally M. Shalaby, Heba F. Pasha, Amany M. Abou El-Saoud, Amany R. El-Najjar, Eman E. El-Shahawy, Polymorphismes de PADI4 et de ses haplotypes chez les patients atteints de polyarthrite rhumatoïde, Revue du Rhumatisme, 2011,

    CrossRef

  15. 15
    K. Van Steendam, K. Tilleman, D. Deforce, The relevance of citrullinated vimentin in the production of antibodies against citrullinated proteins and the pathogenesis of rheumatoid arthritis, Rheumatology, 2011, 50, 5, 830

    CrossRef

  16. 16
    Günter Steiner, Markus Hoffmann, Rheumatology, 2011,

    CrossRef

  17. 17
    Altan Ercan, Jing Cui, Dereck E. W. Chatterton, Kevin D. Deane, Melissa M. Hazen, William Brintnell, Colin I. O'Donnell, Lezlie A. Derber, Michael E. Weinblatt, Nancy A. Shadick, David A. Bell, Ewa Cairns, Daniel H. Solomon, V. Michael Holers, Pauline M. Rudd, David M. Lee, Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis, Arthritis & Rheumatism, 2010, 62, 8
    Direct Link:
  18. 18
    Isabella Lima, Mittermayer Santiago, Antibodies against cyclic citrullinated peptides in infectious diseases—a systematic review, Clinical Rheumatology, 2010, 29, 12, 1345

    CrossRef

  19. 19
    Andrea Tesija-Kuna, Simeon Grazio, Marijana Miler, Ines Vukasovic, Porin Peric, Nada Vrkic, Antibodies targeting mutated citrullinated vimentin in patients with psoriatic arthritis, Clinical Rheumatology, 2010, 29, 5, 487

    CrossRef

  20. 20
    Hüseyin Uysal, Kutty Selva Nandakumar, Christoph Kessel, Sabrina Haag, Stefan Carlsen, Harald Burkhardt, Rikard Holmdahl, Antibodies to citrullinated proteins: molecular interactions and arthritogenicity, Immunological Reviews, 2010, 233, 1
    Direct Link:
  21. 21
    Omri Snir, Mona Widhe, Monika Hermansson, Caroline von Spee, Johan Lindberg, Sanne Hensen, Karin Lundberg, Åke Engström, Patrick J. W. Venables, René E. M. Toes, Rikard Holmdahl, Lars Klareskog, Vivianne Malmström, Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients, Arthritis & Rheumatism, 2010, 62, 1
    Direct Link:
  22. 22
    Natalia Wegner, Karin Lundberg, Andrew Kinloch, Benjamin Fisher, Vivianne Malmström, Marc Feldmann, Patrick J. Venables, Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis, Immunological Reviews, 2010, 233, 1
    Direct Link:
  23. 23
    Pieter W. A. Meyer, Bridget Hodkinson, Mahmood Ally, Eustasius Musenge, Ahmed A. Wadee, Heidi Fickl, Mohammed Tikly, Ronald Anderson, Circulating Cytokine Profiles and Their Relationships with Autoantibodies, Acute Phase Reactants, and Disease Activity in Patients with Rheumatoid Arthritis, Mediators of Inflammation, 2010, 2010, 1

    CrossRef

  24. 24
    Stanislav LUBAN, Zhan-Guo LI, Citrullinated peptide and its relevance to rheumatoid arthritis: an update, International Journal of Rheumatic Diseases, 2010, 13, 4
    Direct Link:
  25. 25
    Che Hussin Che MARAINA, Abdul Karim NURDAYANA, Dollah RUSNI, Yaacob AZWANY, Diagnostic value of anti-modified citrullinated vimentin in rheumatoid arthritis, International Journal of Rheumatic Diseases, 2010, 13, 4
    Direct Link:
  26. 26
    Lie Ying Fan, Ming Zong, Qiang Wang, Lin Yang, Li Shan Sun, Qin Ye, Yuan Yuan Ding, Jian Wei Ma, Diagnostic value of glucose-6-phosphate isomerase in rheumatoid arthritis, Clinica Chimica Acta, 2010, 411, 23-24, 2049

    CrossRef

  27. You have free access to this content27
    Michael Mahler, Marvin J. Fritzler, Epitope specificity and significance in systemic autoimmune diseases, Annals of the New York Academy of Sciences, 2010, 1183, 1
    Direct Link:
  28. 28
    H. Maciejewska-Rodrigues, M. Al-Shamisi, H. Hemmatazad, C. Ospelt, M. C. Bouton, D. Jäger, A. P. Cope, P. Charles, D. Plant, J. H. W. Distler, R. E. Gay, B. A. Michel, A. Knuth, M. Neidhart, S. Gay, A. Jüngel, Functional autoantibodies against serpin E2 in rheumatoid arthritis, Arthritis & Rheumatism, 2010, 62, 1
    Direct Link:
  29. 29
    Xue Qin, Yan Deng, Jing Xu, Tai-Jie Li, Shan Li, Jin-Min Zhao, Meta-analysis: diagnostic value of serum anti-mutated citrullinated vimentin antibodies in patients with rheumatoid arthritis, Rheumatology International, 2010, 31, 6, 785

    CrossRef

  30. 30
    J. Heinert, C. Iking-Konert, M. Blumenroth, O. Sander, J. Richter, M. Schneider, Neuer Ansatz zur Früherkennung entzündlich-rheumatischer Erkrankungen in der Bevölkerung, Zeitschrift für Rheumatologie, 2010, 69, 8, 743

    CrossRef

  31. 31
    Martina Fabris, Salvatore Vita, Nadia Blasone, Daniela Visentini, Elena Pezzarini, Elena Pontarini, Cinzia Fabro, Luca Quartuccio, Saulle Mazzolini, Francesco Curcio, Elio Tonutti, Serum levels of anti-CCP antibodies, anti-MCV antibodies and RF IgA in the follow-up of patients with rheumatoid arthritis treated with rituximab, Autoimmunity Highlights, 2010, 1, 2, 87

    CrossRef

  32. 32
    Ann Duskin, Robert A. Eisenberg, The role of antibodies in inflammatory arthritis, Immunological Reviews, 2010, 233, 1
    Direct Link:
  33. 33
    Hans Ulrich Scherer, Gerd R. Burmester, A clinical perspective of rheumatoid arthritis, European Journal of Immunology, 2009, 39, 8
    Direct Link:
  34. 34
    Rohit Aggarwal, Katherine Liao, Raj Nair, Sarah Ringold, Karen H. Costenbander, Anti–citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis, Arthritis Care & Research, 2009, 61, 11
    Direct Link:
  35. 35
    Marc C. Levesque, Zhijie Zhou, Larry W. Moreland, Anti–cyclic citrullinated peptide testing for the diagnosis of rheumatoid arthritis and the quest for improved sensitivity and predictive value, Arthritis & Rheumatism, 2009, 60, 8
    Direct Link:
  36. 36
    Andrea Tesija Kuna, Lovro Lamot, Marijana Miler, Miroslav Harjacek, Ana-Maria Simundic, Nada Vrkic, Antibodies to mutated citrullinated vimentin and antibodies to cyclic citrullinated peptides in juvenile idiopathic arthritis, Clinical Chemistry and Laboratory Medicine, 2009, 47, 12, 1525

    CrossRef

  37. 37
    R. Engelmann, B. Müller-Hilke, Antikörper gegen citrullinierte Peptidantigene in Klinik und Forschung, Zeitschrift für Rheumatologie, 2009, 68, 6, 485

    CrossRef

  38. 38
    Licia Maria Henrique Mota, Leopoldo Luiz Santos Neto, Jozélio Freire Carvalho, Autoantibodies and other serological markers in rheumatoid arthritis: predictors of disease activity?, Clinical Rheumatology, 2009, 28, 10, 1127

    CrossRef

  39. 39
    A. Gyetvai, Z. Szekanecz, L. Soos, Z. Szabo, A. Fekete, A. Kapitany, M. Teodorescu, S. Sipka, G. Szegedi, G. Lakos, New classification of the shared epitope in rheumatoid arthritis: impact on the production of various anti-citrullinated protein antibodies, Rheumatology, 2009, 49, 1, 25

    CrossRef

  40. 40
    Kutty Selva Nandakumar, Pathogenic antibody recognition of cartilage, Cell and Tissue Research, 2009, 339, 1, 213

    CrossRef

  41. 41
    Karim Raza, Andrew Filer, Predicting the development of RA in patients with early undifferentiated arthritis, Best Practice & Research Clinical Rheumatology, 2009, 23, 1, 25

    CrossRef

  42. 42
    Jinxia Zhao, Xiangyuan Liu, Zhimin Wang, Zhanguo Li, Significance of anti-CCP antibodies in modification of 1987 ACR classification criteria in diagnosis of rheumatoid arthritis, Clinical Rheumatology, 2009, 29, 1, 33

    CrossRef

  43. 43
    Nathalie Carrier, Pierre Cossette, Claude Daniel, Artur de Brum-Fernandes, Patrick Liang, Henri A. Ménard, Gilles Boire, The DERAA HLA–DR alleles in patients with early polyarthritis: Protection against severe disease and lack of association with rheumatoid arthritis autoantibodies, Arthritis & Rheumatism, 2009, 60, 3
    Direct Link:
  44. 44
    Michael P. M. van der Linden, Diane van der Woude, Andreea Ioan-Facsinay, E. W. Nivine Levarht, Gerrie Stoeken-Rijsbergen, Tom W. J. Huizinga, René E. M. Toes, Annette H. M. van der Helm-van Mil, Value of anti–modified citrullinated vimentin and third-generation anti–cyclic citrullinated peptide compared with second-generation anti–cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis, Arthritis & Rheumatism, 2009, 60, 8
    Direct Link:
  45. 45
    Jana Posalski, Michael H. Weisman, Rheumatoid Arthritis, 2009,

    CrossRef

  46. 46
    Walther J. Van Venrooij, Joyce J.B.C. Van Beers, Ger J.M. Pruijn, Anti-CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis, Annals of the New York Academy of Sciences, 2008, 1143, 1
    Direct Link:
  47. 47
    R. Engelmann, J. Brandt, M. Eggert, K. Karberg, A. Krause, G. Neeck, B. Mueller-Hilke, IgG1 and IgG4 are the predominant subclasses among auto-antibodies against two citrullinated antigens in RA, Rheumatology, 2008, 47, 10, 1489

    CrossRef

  48. 48
    Nicole Fabien, Joëlle Goetz, Christelle Sordet, René-Louis Humbel, Jean Sibilia, Nouveaux autoanticorps de la polyarthrite rhumatoïde : les autoanticorps anti-peptides ou protéines citrullinées et les autres, La Presse Médicale, 2008, 37, 12, 1756

    CrossRef

  49. 49
    Zoltán Szekanecz, Gabriella Lakos, Rheumatoid arthritis diagnosis with antimutated citrullinated vimentin ELISA by Orgentec Diagnostika, Expert Opinion on Medical Diagnostics, 2008, 2, 9, 1083

    CrossRef

View Full Article (HTML) Get PDF (239K)